FUNDING
Publications
2023
2022
Immunotherapy approaches for the treatment of diffuse midline gliomas.
Bernstock JD, Hoffman SE, Kappel AD, Valdes PA, Essayed W, Klinger NV, Kang KD, Totsch SK, Olsen HE, Schlappi CW, Filipski K, Gessler FA, Baird L, Filbin MG, Hashizume R, Becher OJ, Friedman GK.
Oncoimmunology. 2022 Sep 26;11(1):2124058. doi: 10.1080/2162402X.2022.2124058. eCollection 2022. PMID: 36185807
Standard clinical approaches and emerging modalities for glioblastoma imaging.
Bernstock JD, Gary SE, Klinger N, Valdes PA, Ibn Essayed W, Olsen HE, Chagoya G, Elsayed G, Yamashita D, Schuss P, Gessler FA, Paolo Peruzzi P, Bag AK, Friedman GK.
Neurooncol Adv. 2022 May 26;4(1):vdac080. doi: 10.1093/noajnl/vdac080. eCollection 2022 Jan-Dec. PMID: 35821676
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells.
Bhere D, Choi SH, van de Donk P, Hope D, Gortzak K, Kunnummal A, Khalsa J, Revai Lechtich E, Reinshagen C, Leon V, Nissar N, Bi WL, Feng C, Li H, Zhang YS, Liang SH, Vasdev N, Essayed W, Quevedo PV, Golby A, Banouni N, Palagina A, Abdi R, Fury B, Smirnakis S, Lowe A, Reeve B, Hiller A, Chiocca EA, Prestwich G, Wakimoto H, Bauer G, Shah K.
Nat Commun. 2022 May 19;13(1):2810. doi: 10.1038/s41467-022-30558-3.
PMID: 35589724
2021
Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies.
Olsen HE, Lynn GM, Valdes PA, Cerecedo Lopez CD, Ishizuka AS, Arnaout O, Bi WL, Peruzzi PP, Chiocca EA, Friedman GK, Bernstock JD.
Neurooncol Adv. 2021 Feb 11;3(1):vdab027. doi: 10.1093/noajnl/vdab027. eCollection 2021 Jan-Dec. PMID: 33860227